Home NDC 17856-4047 Carbamazepine
Product NDC 17856-4047
11-digit product format 178564047
Labeler code 17856
Product ID 17856-4047_30a4fdec-3fbc-034c-e063-6294a90aa786
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Carbamazepine
Dosage form SUSPENSION
Route ORAL
Labeler Atlantic Biologicals Corps
Application ANDA076729
Marketing category ANDA
Marketing start 2004-09-20
Substance CARBAMAZEPINE
Active strength 100 mg/5mL
Pharmacologic classes Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 36 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-03-22 03:12 UTC · source 2025-03-21 excluded product product I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 17856-4047-1 I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 17856-4047-1 I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 17856-4047-1 I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 17856-4047-1 I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 17856-4047-1 I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 17856-4047-1 I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 17856-4047-1 I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 17856-4047-1 I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 excluded product product I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-28 21:12 UTC · source 2024-05-28 excluded package package 17856-4047-1 I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 excluded product product I Inactivated by FDA 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 17856-4047-1 I Inactivated by FDA 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 excluded product product I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 17856-4047-1 I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2022-08-30 03:57 UTC · source 2022-08-29 excluded product product I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-08-30 03:57 UTC · source 2022-08-29 excluded package package 17856-4047-1 I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-04-09 23:13 UTC · source 2022-04-08 excluded product product I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-09 23:13 UTC · source 2022-04-08 excluded package package 17856-4047-1 I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-04 05:40 UTC · source 2022-04-01 excluded product product I Inactivated by FDA bd6a592717d7…303034d00443…2022-04-04 05:40 UTC · source 2022-04-01 excluded package package 17856-4047-1 I Inactivated by FDA bd6a592717d7…303034d00443…2021-12-27 23:28 UTC · source 2021-12-27 excluded product product I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2021-12-27 23:28 UTC · source 2021-12-27 excluded package package 17856-4047-1 I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2020-12-18 03:04 UTC · source 2020-12-17 excluded product product I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-12-18 03:04 UTC · source 2020-12-17 excluded package package 17856-4047-1 I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-06-10 20:45 UTC · source 2020-06-10 excluded product product I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2020-06-10 20:45 UTC · source 2020-06-10 excluded package package 17856-4047-1 I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2019-12-08 06:16 UTC · source 2019-12-05 excluded product product E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…2019-12-08 06:16 UTC · source 2019-12-05 excluded package package 17856-4047-1 E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A076729-001 TERIL CARBAMAZEPINE 100MG/5ML SUSPENSION / ORAL AB 2004-09-20
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A076729-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 41 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A076729-001 TERIL 100MG/5ML SUSPENSION / ORAL AB 2004-09-20 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A076729-001 TERIL 100MG/5ML SUSPENSION / ORAL AB 2004-09-20 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A076729-001 TERIL 100MG/5ML SUSPENSION / ORAL AB 2004-09-20 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A076729-001 TERIL 100MG/5ML SUSPENSION / ORAL AB 2004-09-20 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A076729-001 TERIL 100MG/5ML SUSPENSION / ORAL AB 2004-09-20 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A076729-001 TERIL 100MG/5ML SUSPENSION / ORAL AB 2004-09-20 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A076729-001 TERIL 100MG/5ML SUSPENSION / ORAL AB 2004-09-20 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A076729-001 TERIL 100MG/5ML SUSPENSION / ORAL AB 2004-09-20 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A076729-001 TERIL 100MG/5ML SUSPENSION / ORAL AB 2004-09-20 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A076729-001 TERIL 100MG/5ML SUSPENSION / ORAL AB 2004-09-20 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A076729-001 TERIL 100MG/5ML SUSPENSION / ORAL AB 2004-09-20 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A076729-001 TERIL 100MG/5ML SUSPENSION / ORAL AB 2004-09-20 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A076729-001 TERIL 100MG/5ML SUSPENSION / ORAL AB 2004-09-20 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A076729-001 TERIL 100MG/5ML SUSPENSION / ORAL AB 2004-09-20 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A076729-001 TERIL 100MG/5ML SUSPENSION / ORAL AB 2004-09-20 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A076729-001 TERIL 100MG/5ML SUSPENSION / ORAL AB 2004-09-20 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A076729-001 TERIL 100MG/5ML SUSPENSION / ORAL AB 2004-09-20 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A076729-001 TERIL 100MG/5ML SUSPENSION / ORAL AB 2004-09-20 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A076729-001 TERIL 100MG/5ML SUSPENSION / ORAL AB 2004-09-20 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A076729-001 TERIL 100MG/5ML SUSPENSION / ORAL AB 2004-09-20 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A076729-001 TERIL 100MG/5ML SUSPENSION / ORAL AB 2004-09-20 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A076729-001 TERIL 100MG/5ML SUSPENSION / ORAL AB 2004-09-20 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A076729-001 TERIL 100MG/5ML SUSPENSION / ORAL AB 2004-09-20 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A076729-001 TERIL 100MG/5ML SUSPENSION / ORAL AB 2004-09-20 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A076729-001 TERIL 100MG/5ML SUSPENSION / ORAL AB 2004-09-20 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A076729-001 TERIL 100MG/5ML SUSPENSION / ORAL AB 2004-09-20 b00525d2431f…2019-07-19 19:46 UTC 2019-07 A076729-001 TERIL 100MG/5ML SUSPENSION / ORAL AB 2004-09-20 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A076729-001 TERIL 100MG/5ML SUSPENSION / ORAL AB 2004-09-20 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A076729-001 TERIL 100MG/5ML SUSPENSION / ORAL AB 2004-09-20 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A076729-001 TERIL 100MG/5ML SUSPENSION / ORAL AB 2004-09-20 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A076729-001 TERIL 100MG/5ML SUSPENSION / ORAL AB 2004-09-20 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A076729-001 TERIL 100MG/5ML SUSPENSION / ORAL AB 2004-09-20 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A076729-001 TERIL 100MG/5ML SUSPENSION / ORAL AB 2004-09-20 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A076729-001 TERIL 100MG/5ML SUSPENSION / ORAL AB 2004-09-20 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A076729-001 TERIL 100MG/5ML SUSPENSION / ORAL AB 2004-09-20 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A076729-001 TERIL 100MG/5ML SUSPENSION / ORAL AB 2004-09-20 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A076729-001 TERIL 100MG/5ML SUSPENSION / ORAL AB 2004-09-20 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A076729-001 TERIL 100MG/5ML SUSPENSION / ORAL AB 2004-09-20 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A076729-001 TERIL 100MG/5ML SUSPENSION / ORAL AB 2004-09-20 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A076729-001 TERIL 100MG/5ML SUSPENSION / ORAL AB 2004-09-20 cb3db0bc1861…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 41 observed states.
Additional Listing Data#
Finished product Yes
Brand name base Carbamazepine
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength CARBAMAZEPINE 100 mg/5mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 33CM23913M Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 308976 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 17856-4047-1 Carbamazepine 10 mL in 1 CUP SUSPENSION 10 3
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 17856-4047 CARBAMAZEPINE SUSPENSION [ATLANTIC BIOLOGICALS CORPS] 3 Current NDC, Legacy NDC, 1 package rows 20250321_25939406-a836-43cd-9301-56808e9b31ec.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 17856-4047-1 17856404701 10 mL in 1 CUP (17856-4047-1) 10 ml 2015-04-28 No No Current